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An attempt to estimate parameters useful for establishing
a normal range for peak nasal inspiratory flow
Próba oceny parametrów przydatnych do wyznaczenia normy dla nosowego
szczytowego przepływu wdechowego
Abstract
Introduction: Measurement of peak nasal inspiratory flow (PNIF) has gained wide acceptance among clinicians due to its
simplicity. Unfortunately, due to the lack of reference values, a single measurement does not provide any relevant informa-
tion on the degree of nasal obstruction. We have therefore attempted to evaluate parameters that would be useful for
establishing reference ranges for PNIF.
Material and methods: The study was a part of an epidemiological study ECAP (Epidemiologia Chorób Alergicznych w
Polsce [The Epidemiology of Allergic Diseases in Poland]). Inhabitants of Wrocław, Poland, aged 6–7, 13–14 and 20–45
years were randomly selected for the study. All the subjects had their medical history taken and their PNIF measured (using
an In-Check inspiratory flow meter manufactured by Clement-Clark). Patients with a diagnosis of rhinitis and/or asthma were
excluded from the study. In each subject, the highest of the five measurements (PNIF MAX) was included in the analysis.
Results: A total of 221 healthy individuals were enrolled in the study. PNIF MAX differed significantly between females and
males. A significant correlation was observed between height and PNIF MAX, although no such correlation was found
between age and PNIF MAX. For this reason, in order to establish a reference range for PNIF, a regression equation that
included sex and height was analysed. The following relationship was arrived at: PNIF MAX = –137.7 – 22.5x + 1.7y,
where x is the sex (1 for females and 0 for males) and y is the height. The coefficient of determination (R2) for this relationship
was 0.45, which means that the regression equation explains about 45% of the observed variability of PNIF MAX.
Conclusions: We found that PNIF MAX correlated with sex and height and that it did not correlate with age. The difficulties
in establishing normal ranges for PNIF are most likely due to the differences in nasal anatomy between the subjects.
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Introduction
Obstruction of nasal passages is a common symp-
tom of rhinitis. The degree of obstruction is difficult
to establish through physical examination. Objective
methods of measurement, such as rhinomanometry,
are therefore used. Because rhinomanometry requires
specialist equipment and the interpretation of results
is difficult, this method is not in widespread use.
The measurement of peak nasal inspiratory
flow (PNIF) has gained wide acceptance among cli-
nicians thanks to its simplicity and the use of an
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easy-to-operate portable measuring device. PNIF is
the simplest measure of nasal obstruction and may
also be determined at home. Unfortunately, due to
the lack of normal ranges, a single measurement
does not provide any relevant information on na-
sal obstruction. This does not diminish the signi-
ficance of widespread use of multiple measure-
ments of this parameter in challenge tests or in the
evaluation of therapeutic effects of drugs [1–6].
We therefore attempted to evaluate some of the
parameters that would potentially be useful for
establishing reference ranges for PNIF.
Material and methods
The study was a part of an epidemiological stu-
dy ECAP (Epidemiologia Chorób Alergicznych w Pol-
sce [The Epidemiology of Allergic Diseases in Poland]).
Children aged 6–7 and 13–14 years and adults aged
20–45 years, all inhabitants of Wrocław, Poland, were
randomly selected for the study. The study sample was
compiled by random selection of PESEL numbers.
Each subject had his or her medical history
taken, had their PNIF measured and underwent an-
terior rhinoscopy. Individuals with a diagnosis of
rhinitis and/or asthma were excluded from the stu-
dy. PNIF was measured with an In-Check inspira-
tory flow meter manufactured by Clement-Clark.
Each subject received appropriate instructions and
took five measurements under supervision of a
doctor. The highest of the five recorded measure-
ments (PNIF MAX) was included in the analysis.
The results were compiled using Statistica 9.
The normality of the distribution was checked with
the Shapiro-Wilk test. As the investigated parame-
ters did not show a normal distribution, non-para-
metric tests were used for comparisons. The inve-
stigated parameters were described by median,
minimum and maximum values (Me, Min–Max).
The comparison of two independent samples was
performed using the Kolmogorov-Smirnov test,
while the Wilcoxon signed-rank test was used for
dependent samples. The comparisons of three gro-
ups of patients were performed using Kruskal-Wal-
lis ANOVA or Friedman ANOVA. A regression equ-
ation was used to establish the reference ranges.
The study was approved by the Medical Univer-
sity of Warsaw Bioethics Committee and the Chief
Inspector for Personal Data Protection. The subjects
gave written consent to participate in the study.
Results
A total of 333 subjects (including 174 [52%]
females) completed the study. Ninety-one of them
gave a history of symptoms suggestive of rhinitis
or asthma and were excluded from further partici-
pation. Table 1 summarises the characteristics of
the remaining 221 healthy subjects. The study sub-
jects were divided into three age groups: younger
children (6–8 years of age), older children (13–14
years of age) and adults (20–45 years of age).
All the subjects measured their PNIF for the
first time in their lives. Each subject performed a
total of five measurements and the highest value
(PNIF MAX) was included in further analysis. Fi-
gure 1 shows histograms for PNIF MAX in specific
groups of the subjects.
PNIF MAX differed significantly between the
group of females and the group of males. A stati-
stically significant correlation was observed betwe-
en height and PNIF MAX, although no such corre-
lation was found between age and PNIF MAX. For
this reason, in order to establish a reference range
for PNIF, a regression equation that included sex
and height was analysed. Figure 2 shows scatter-
plots of PNIF MAX values relative to height in the
group of females and in the group of males.
The following relationship was arrived at:
PNIF MAX = –137.7 – 22.5x + 1.7y, where x is the
sex (1 for females and 0 for males) and y is the
height. The coefficient of determination (R2) for this
relationship was 0.45, which means that the regres-
sion equation explains about 45% of the observed
variability of PNIF MAX.
Discussion
Measurement of PNIF has become widely used
in clinical practice to assess the degree of nasal
obstruction despite multiple problems encounte-
red while interpreting the results. Concerns are
raised by the repeatability of the measurements,
correlation of the result with the severity of symp-
toms assessed by the patients and, most importan-
tly, by the lack of defined reference ranges for this
parameter. In 2006, the attempt to establish the
reference ranges in a group of 170 healthy indivi-
duals failed due to the considerable variability of
PNIF between the subjects [7].
A smaller study led to similar results: statisti-
cally significant differences between men and
women, a correlation between PNIF and height and
the lack of correlation between PNIF and age. Ho-
wever, the regression equation with these variables
describes a mere 45% of the values obtained. This
may be associated with a correlation between PNIF
and other parameters, such as spirometric parame-
ters, for instance. Such a correlation was found in
a study published in 2005 [1]. The study showed a
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Table 1. Characteristics of the patients according to age and sex
The test parameter Median Minimum Maximum Mean ± SD
Total (n = 221)
Age (y) 14 6 54 17,5 ± 11,2
Height [cm] 163 108 191 154,7 ± 20,7
PNIF MAX [l/min] 110 40 320 121,6 ± 58,5
Children 6 years (n = 73)
Age (y) 7 6 8 6,6 ± 0,6
Height [cm] 128 108 140 125,9 ± 7,1
PNIF MAX [l/min] 70 40 170 75,0 ± 23,6
Children 13 years (n = 82)
Age (y) 14 11 15 13,6 ± 0,7
Height [cm] 165 145 191 165,0 ± 8,4
PNIF MAX [l/min] 130 50 290 134,2 ± 53,4
Adults 20 years (n = 66)
Age (y) 29 20 54 30,7 ± 8,1
Height [cm] 168 154 190 169,3 ± 8,4
PNIF MAX [l/min] 132 40 320 151,1 ± 59,4
Female (n = 108)
The test parameter Median Minimum Maximum Mean ± SD
Total (n = 108)
Age (y) 14 6 54 19,5 ± 11,5
Height [cm] 162 108 180 155,4 ± 17,4
PNIF MAX [l/min] 105 40 220 109,4 ± 42,6
Children 6 years (n = 41)
Age (y) 7 6 8 6,48 ± 0,57
Height [cm] 125 108 140 125,37 ± 7,5
PNIF MAX [l/min] 60 40 90 59,4,0 ± 14,6
Children 13 years (n = 38)
Age (y) 14 13 15 13,6 ± 0,6
Height [cm] 164 150 175 162,9 ± 6,7
PNIF MAX [l/min] 100 40 160 120,3 ± 31,9
Adults 20 years (n = 29)
Age (y) 31 20 54 31,5 ± 7,9
Height [cm] 165,5 125 189 165,2 ± 8,6
PNIF MAX [l/min] 180 40 220 140,1 ± 38,1
Male (n = 113)
The test parameter Median Minimum Maximum Mean ± SD
Total (n = 113)
Age (y) 13 6 44 15,2 ± 10,1
Height [cm] 163 110 191 155,0 ± 24,1
PNIF MAX [l/min] 110 40 320 131,1 ± 66,8
Children 6 years (n = 32)
Age (y) 7 6 8 6,74 ± 0,65
Height [cm] 127 111 140 125,6 ± 7,1
PNIF MAX [l/min] 70 40 170 75,0 ± 23,6
Children 13 years (n = 44)
Age (y) 14 13 15 13,59 ± 0,6
Height [cm] 172 147 191 169,0 ± 10,0
PNIF MAX [l/min] 120 60 290 141,2 ± 65,5
Adults 20 years (n = 37)
Age (y) 30 20 44 30,7 ± 8,1
Height [cm] 177 156 190 169,3 ± 8,4
PNIF MAX [l/min] 150 80 320 166,6 ± 57,4
PNIF MAX — maximum peak nasal inspiratory flow; SD — standard deviation
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Figure 1. Histograms of maximum peak nasal inspiratory flow — total sample and groups
correlation between PNIF and forced vital capaci-
ty (FVC) and forced expiratory volume in one se-
cond (FEV1). This correlation is, however, weak
and accounts for a small part of the PNIF variabi-
lity (15%).
It seems that a significant role in PNIF varia-
bility may be played by differences in nasal ana-
tomy between the subjects, which may also be sup-
ported by the large range of PNIF values in the gro-
up of adults (40–320 ml/s). In this case establishing
reference ranges for this parameter would be impos-
sible. However, this does not diminish the useful-
ness of PNIF measurement in the assessment of
nasal obstruction in a given person after the perso-
nal best has been determined. The change in PNIF
is most commonly used in practice to confirm an
increasing nasal obstruction in challenge testing.
Conclusions
1. A correlation between PNIF and sex and be-
tween PNIF and height has been found with
no correlation being observed between PNIF
and age.
2. The difficulties in establishing reference ran-
ges for PNIF are most likely a result of the dif-
ferences in nasal anatomy between individu-
al subjects. It therefore seems that reference
ranges established in population studies ta-
king into account age and height cannot be
characterised by satisfactory accuracy.
3. PNIF may be a valuable measure used to ob-
jectify the assessment of the clinical course of
rhinitis but only after the so-called personal
best has been determined.
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Figure 2. Scatterplots of peak nasal inspiratory flow depending on the height in women and men
